Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase subunit G1 (ATP6V1G1) is a core component of the V1 domain of the vacuolar-type H^(+)-ATPase (V-ATPase), a multisubunit enzyme transporter complex responsible for the acidification of eukaryotic intracellular organelles such as lysosomes, endosomes, and synaptic vesicles. This acidification is crucial for processes including protein degradation, receptor-mediated endocytosis, protein sorting, and neurotransmitter loading into vesicles. Dysregulation or mutation of ATP6V1G1 is associated with human disease, notably optic atrophy 6; the V-ATPase complex has broader implications in pathologies including neurodegeneration and cancer. ATP6V1G1 does not have specific approved drugs but is researched as part of the V-ATPase complex, especially using inhibitors like bafilomycin A1.
Inhibition of proton transport/acidification by V-ATPase; can impact cellular pH, lysosomal function, and vesicle trafficking
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase subunit G1 (ATP6V1G1).